These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18477571)

  • 1. Is sialylation of IgA the agent provocateur of IgA nephropathy?
    Smith A; Molyneux K; Feehally J; Barratt J
    Nephrol Dial Transplant; 2008 Jul; 23(7):2176-8. PubMed ID: 18477571
    [No Abstract]   [Full Text] [Related]  

  • 2. IgA nephropathy: overproduction or decreased clearance of immune complexes?
    Emancipator SN; Lamm ME
    Lab Invest; 1989 Oct; 61(4):365-7. PubMed ID: 2796286
    [No Abstract]   [Full Text] [Related]  

  • 3. IgA1 glycosylation in IgA nephropathy: as sweet as it can be.
    Eijgenraam JW; van Kooten C
    Kidney Int; 2008 May; 73(10):1106-8. PubMed ID: 18449177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA-CD89 complex in IgA nephropathy: a study on molecular function.
    Wiwanitkit V
    Ren Fail; 2006; 28(6):457-9. PubMed ID: 16928613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J; Smith AC; Feehally J
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of the beta1,3- galactosyltransferase gene in tonsillar B lymphocytes and aberrant lectin bindings to tonsillar IgA as a pathogenesis of IgA nephropathy.
    Inoue T; Sugiyama H; Kikumoto Y; Fukuoka N; Maeshima Y; Hattori H; Fukushima K; Nishizaki K; Hiki Y; Makino H
    Contrib Nephrol; 2007; 157():120-4. PubMed ID: 17495448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental IgA nephropathy. Factors governing the persistence of IgA-antigen complexes in the circulation of mice.
    Rifai A; Small P; Ayoub EM
    Contrib Nephrol; 1984; 40():37-44. PubMed ID: 6499461
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathogenetic aspects of IgA nephropathy.
    Rantala I; Mustonen J; Hurme M; Syrjänen J; Helin H
    Nephron; 2001 Jul; 88(3):193-8. PubMed ID: 11423748
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased miR-374b promotes cell proliferation and the production of aberrant glycosylated IgA1 in B cells of IgA nephropathy.
    Hu S; Bao H; Xu X; Zhou X; Qin W; Zeng C; Liu Z
    FEBS Lett; 2015 Dec; 589(24 Pt B):4019-25. PubMed ID: 26545495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue distribution and biological activities of immune complexes are determined by their size and composition.
    Matousovic K; Novak J; Julian BA; Mestecky J
    Nephrol Dial Transplant; 2010 Mar; 25(3):1007. PubMed ID: 19914998
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune complex formation in IgA nephropathy: CD89 a 'saint' or a 'sinner'?
    Boyd JK; Barratt J
    Kidney Int; 2010 Dec; 78(12):1211-3. PubMed ID: 21116273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrantly glycosylated IgA1 in glomerular immune deposits of IgA nephropathy.
    Giannakakis K; Feriozzi S; Perez M; Faraggiana T; Muda AO
    J Am Soc Nephrol; 2007 Dec; 18(12):3139-46. PubMed ID: 17978312
    [No Abstract]   [Full Text] [Related]  

  • 13. Activity of alpha2,6-sialyltransferase and its gene expression in peripheral B lymphocytes in patients with IgA nephropathy.
    Ding JX; Xu LX; Zhu L; Lv JC; Zhao MH; Zhang H; Wang HY
    Scand J Immunol; 2009 Feb; 69(2):174-80. PubMed ID: 19170967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal glycosylation of IgA: is it related to the pathogenesis of IgA nephropathy?
    Allen AC
    Nephrol Dial Transplant; 1995; 10(7):1121-4. PubMed ID: 7478108
    [No Abstract]   [Full Text] [Related]  

  • 15. IgA glycosylation in IgA nephropathy.
    Allen A; Feehally J
    Adv Exp Med Biol; 1998; 435():175-83. PubMed ID: 9498076
    [No Abstract]   [Full Text] [Related]  

  • 16. New insights into the pathogenesis of IgA nephropathy. Pathogenesis of IgA nephropathy.
    Smith AC; Feehally J
    Springer Semin Immunopathol; 2003 May; 24(4):477-93. PubMed ID: 12778340
    [No Abstract]   [Full Text] [Related]  

  • 17. IgA1 glycosylation and the pathogenesis of IgA nephropathy.
    Allen AC; Feehally J
    Am J Kidney Dis; 2000 Mar; 35(3):551-6. PubMed ID: 10692287
    [No Abstract]   [Full Text] [Related]  

  • 18. IgA nephropathy.
    Wardle EN
    N Engl J Med; 2003 Jan; 348(1):79-81; author reply 79-81. PubMed ID: 12510692
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction of IgA deposits and glomerulonephritis by IgA rheumatoid factor.
    Novak J
    J Am Soc Nephrol; 2012 Mar; 23(3):371-3. PubMed ID: 22323642
    [No Abstract]   [Full Text] [Related]  

  • 20. [Progression in the mechanism of the Cosmc in IgA nephropathy].
    Zhou N; Shen Y
    Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):549-51. PubMed ID: 24267143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.